Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A) [completed] May 4, 2022https://clinicaltrials.gov/ct2/show/NCT05361031 Engensis (VM202)
